Literature DB >> 3246597

Differences among Shigella spp. in susceptibility to the bactericidal activity of human serum.

N Okamura1, R Nakaya, K Suzuki, S Kondo, K Hisatsune, Y Imagawa, H Sagara, Y Matsubara.   

Abstract

Clinical isolates of Shigella spp. were examined for their susceptibility to human serum. The susceptibility of the strains to immune and nonimmune human serum was dependent upon the size of the bacterial inoculum and the concentration of serum. There were differences among Shigella spp. in susceptibility to human serum: S. sonnei strains were the least susceptible, strains of S. boydii and S. flexneri serotype 6 were intermediate, and those of S. flexneri other than serotype 6 and S. dysenteriae were the most susceptible. Experiments in which heat-treated (56 degrees C for 30 min, or 50 degrees C for 20 min) serum was used, and analysis of activation of complement by lipopolysaccharides (LPS) from each Shigella sp., suggested that LPS composition, especially the O antigen polysaccharide chains, contributes to the differences among Shigella spp. in susceptibility to human serum.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3246597     DOI: 10.1099/00221287-134-7-2057

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  4 in total

Review 1.  Shigella: a model of virulence regulation in vivo.

Authors:  Benoit Marteyn; Anastasia Gazi; Philippe Sansonetti
Journal:  Gut Microbes       Date:  2012-03-01

2.  An O antigen capsule modulates bacterial pathogenesis in Shigella sonnei.

Authors:  Mariaelena Caboni; Thierry Pédron; Omar Rossi; David Goulding; Derek Pickard; Francesco Citiulo; Calman A MacLennan; Gordon Dougan; Nicholas R Thomson; Allan Saul; Philippe J Sansonetti; Christiane Gerke
Journal:  PLoS Pathog       Date:  2015-03-20       Impact factor: 6.823

3.  Role of a fluid-phase PRR in fighting an intracellular pathogen: PTX3 in Shigella infection.

Authors:  Valeria Ciancarella; Luigi Lembo-Fazio; Ida Paciello; Anna-Karin Bruno; Sébastien Jaillon; Sara Berardi; Marialuisa Barbagallo; Shiri Meron-Sudai; Dani Cohen; Antonio Molinaro; Giacomo Rossi; Cecilia Garlanda; Maria Lina Bernardini
Journal:  PLoS Pathog       Date:  2018-12-07       Impact factor: 6.823

Review 4.  Functional antibodies as immunological endpoints to evaluate protective immunity against Shigella.

Authors:  Esther Ndungo; Marcela F Pasetti
Journal:  Hum Vaccin Immunother       Date:  2019-08-01       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.